Understanding Neuropsychiatric Syndromes in HIV Patients
This educational curriculum explores the role of psychiatry in enhancing outcomes for people living with HIV (PLWH) by addressing cognitive burden, psychiatric disorders prevalence, and appropriate psychopharmacology. Delving into the history, epidemiology, and psychiatry's role, the material covers
0 views • 57 slides
Understanding Co-morbidities in People Living with HIV
Exploring the various co-morbidities associated with HIV infection and factors contributing to their development. Discussions on disease clusters, impact of risk factors such as smoking and cardiovascular disease, and comorbidities in parents of PLWH compared to HIV-negative individuals. Insights in
0 views • 14 slides
Tobacco Reduction in People Living with HIV: Challenges and Solutions
Tobacco use among people living with HIV (PLWH) in Michigan poses a significant health risk, leading to preventable deaths and severe health consequences. The data highlights the high prevalence of smoking among different populations disproportionately impacted by tobacco use. Smoking cigarettes can
0 views • 16 slides
Selected Gilead Abstracts Published at AIDS 2020
The abstracts selected by Gilead Medical Affairs Germany for AIDS 2020 cover a range of topics related to HIV treatment and research. Topics include safety and efficacy of B/F/TAF in older adults, real-world effectiveness of B/F/TAF in clinical practice, prevalence of resistance in PLWH, and the lat
0 views • 13 slides
Safety and Pharmacodynamic Activity of Vesatolimod (GS-9620) in HIV-Infected Individuals
Vesatolimod (GS-9620) has shown to be safe and pharmacodynamically active in individuals infected with HIV. Studies demonstrate its potential to eliminate and activate infected CD4 T cells, recruit immune cells like NK cells and macrophages, and work in combination with broadly neutralizing antibodi
0 views • 21 slides